Jeff Bezos Is Backing An AI Startup Aiming To Make Proteins Programmable
PositiveFinancial Markets

- Profluent has secured $106 million in funding to advance its AI models for biological applications, particularly in drug development and agriculture. This initiative aims to innovate the way proteins are utilized in these sectors.
- The investment signifies a strategic move for Jeff Bezos, who is leveraging his resources to support groundbreaking technology in AI, indicating a renewed focus on the sector despite previous concerns about its sustainability.
- This development reflects a broader trend in the tech industry where significant investments are being made in AI startups, highlighting the ongoing debate about the viability and future of AI technologies amidst market fluctuations.
— via World Pulse Now AI Editorial System







